NDC 0591-0822 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-0822
- Package NDCs from labels
- 0591-0822-01, 0591-0822-05
- Manufacturer
- Watson Labs
- Effective date
- 2007-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - Watson Labs | Watson Labs | 2007-02-06 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0591-0822-01 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 0591-0822-05 | Naproxen | 500 in 1 BOTTLE | TABLET | 500 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Naproxen | ACTIVE INGREDIENT | 57Y76R9ATQ | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Naproxen | ACTIVE MOIETY | 57Y76R9ATQ | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Croscarmellose sodium | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | |
| Povidone | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic black iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic red iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 | ||
| Synthetic yellow iron oxide | INACTIVE INGREDIENT | NAPROXEN (NAPROXEN) TABLET [WATSON LABS] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | QPharma, Inc. | 307aa67f-53b9-4c60-a328-091bbf6338d4 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen Sodium | NAPROXEN SODIUM | Glenmark Pharmaceuticals Inc., USA | 6c5bb008-e66f-4ef0-bf84-aca7eb5983e9 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 |
| NAPROXEN | NAPROXEN | QPharma Inc | c0a4839b-7154-c82c-e053-2a95a90a7e6d | 2025-12-03 | Warnings | 198014 |
| Naproxen | NAPROXEN | PHOENIX RX LLC | 43912294-77c9-eda8-e063-6394a90adf0a | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 8c3398bd-66b1-4a14-8aaa-e4a2d6749a08 | 2025-11-02 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Medcore LLC | 129392c8-8ce1-4b78-8863-042db880095f | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | 198014 |
| NAPROXEN | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | a9f9ce81-9d51-4167-9581-974866a8fe31 | 2025-10-17 | Warnings | 198014 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | e0f430fd-4511-41c8-b5e9-894abe4f3c37 | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | A-S Medication Solutions | cfa88511-40bb-4658-b606-44c68d0746b7 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | A-S Medication Solutions | b500bdba-946a-41ff-855c-1f2937547d01 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 29d98cf3-a0f2-3f89-e054-00144ff88e88 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 198012 |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 6573681e-e9be-440f-a818-a533b744648e | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 198013 |
| Naproxen | NAPROXEN | Proficient Rx LP | e64b3b36-f96e-463e-aca8-8f6e86724bcf | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | 198013 |
| Naproxen | NAPROXEN | Aurobindo Pharma Limited | 0e5315bc-c02f-4749-be69-b5b528327d58 | 2025-06-07 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 |
| Naproxen | NAPROXEN | Amneal Pharmaceuticals LLC | c43a43e2-e867-448d-8f59-3efc7c077cbc | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 7fef9311-471b-472c-b4f2-c952a2b3a255 | 2025-05-07 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Coupler LLC | 3375e139-d9de-8c2d-e063-6394a90a653d | 2025-04-23 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | A-S Medication Solutions | e63a034d-23ef-458f-88ed-8b6d73699621 | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | 198013 |
| Naproxen | NAPROXEN | Asclemed USA, Inc. | 1e406e47-408a-48cc-921e-52882a11581c | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | 198014 |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 9d7bc470-fbba-40a6-a56c-f681a3cee9cf | 2025-03-24 | Boxed warning, Warnings, Adverse reactions | 198014 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.